Ardent Health (ARDT) EVP awarded 34,733 performance-based shares

Rhea-AI Filing Summary

Petrovich Stephen C. reported acquisition or exercise transactions in this Form 4 filing.

Ardent Health, Inc. executive vice president, general counsel and secretary Stephen C. Petrovich was granted 34,733 shares of common stock on March 11, 2026 as a performance-based award. The shares were earned under performance-vesting restricted stock units granted on July 18, 2024 and will vest on December 31, 2026, contingent on continued service.

Following this award, Petrovich directly owns 753,036 shares of Ardent Health common stock. The filing also reports additional indirect holdings of common stock through 2016 exempt family trusts benefiting his children, for which he disclaims beneficial ownership except for any pecuniary interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Petrovich Stephen C.

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC and Secretary

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/11/2026		A		34,733(1)	A	$0	753,036	D
Common Stock								186,225	I	See footnote(2)
Common Stock								186,225	I	See footnote(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares earned based on 2024 and 2025 performance under performance vesting restricted stock units awarded on July 18, 2024. Pursuant to the terms of the award, the shares will vest on December 31, 2026 contingent upon service through such date.

2. These securities are held by Emilie K. Petrovich GST-2016 Exempt Family Trust, of which the Reporting Person is the trustee and the Reporting Person's children are beneficiaries. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interests therein, if any.

3. These securities are held by Stephen C. Petrovich GST-2016 Exempt Family Trust, of which the Reporting Person's spouse is the trustee and the Reporting Person's children are beneficiaries. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interests therein, if any.

Remarks:

	/s/ Stephen C. Petrovich	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Ardent Health (ARDT) report for Stephen C. Petrovich?

Ardent Health reported that EVP, general counsel and secretary Stephen C. Petrovich received 34,733 shares of common stock as a performance-based equity award. The grant reflects shares earned under earlier performance-vesting restricted stock units tied to 2024 and 2025 results.

How many Ardent Health shares did Stephen C. Petrovich acquire in this Form 4 filing?

Stephen C. Petrovich acquired 34,733 shares of Ardent Health common stock at a stated price of $0.00 per share. These shares relate to performance-vesting restricted stock units that were previously granted and have now been earned based on 2024 and 2025 performance.

What are the vesting terms of Stephen C. Petrovich’s new Ardent Health share award?

The 34,733 shares were earned based on 2024 and 2025 performance under performance-vesting restricted stock units awarded on July 18, 2024. Under the award terms, the shares will vest on December 31, 2026, contingent on Mr. Petrovich’s continued service through that date.

What is Stephen C. Petrovich’s Ardent Health share ownership after this transaction?

After the performance-based award, Stephen C. Petrovich holds 753,036 Ardent Health common shares directly. The filing also reports additional indirect holdings through 2016 exempt family trusts benefiting his children, though he disclaims beneficial ownership except for any pecuniary interest.

Are Stephen C. Petrovich’s indirect Ardent Health holdings personally controlled by him?

The indirect holdings are in two 2016 exempt family trusts benefiting his children, one where he is trustee and one where his spouse is trustee. He disclaims beneficial ownership of these securities, except to the extent of any pecuniary interests he may have in them.

Does this Ardent Health Form 4 reflect an open-market stock purchase or sale?

The Form 4 does not show any open-market purchase or sale. It reports a grant-type acquisition coded as a performance-based award at $0.00 per share, along with updated direct and indirect ownership details, rather than discretionary market trading by Stephen C. Petrovich.